Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis.

By M. Schwaber, Yehuda Carmeli. Journal of Antimicrobial Chemotherapy, 2007

652 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Critical Care and Intensive Care Medicine, Molecular Medicine

View Paper: https://www.semanticscholar.org/paper/a1c3443254e7888c6a49f4a4d515c6efa1b318c2

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Critical Care and Intensive Care Medicine

1. Yehuda Carmeli

In Molecular Medicine

1. C. Giske
2. S. Cosgrove

Citations in the corpus

• Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. (2012, neutral): “extended-spectrum -lactamase (ESBL)-producing Enterobacteriaceae [31-33].”
• Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. (2009, neutral): “tality [61, 62].”
• Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli (2007, background): “For the members of the family Enterobacteriaceae, a recent meta-analysis has found increased rates of mortality among patients with BSIs caused by ESBL-producing organisms (67), while a majority of studies of other types of infections found no significant differences attributable to resistance to ex”